Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06411561 · ClinicalTrials.gov registry record · NA
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
A NA study of Dementia and Alzheimers Disease, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06411561 is a NA study of Dementia and Alzheimers Disease that is actively recruiting participants, run by University of Washington. The registered enrollment target is 100 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06411561, a NA study of Dementia and Alzheimers Disease, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after hospital discharge. Older ICU survivors (ages 60 and older) are at highest risk for delirium and subsequent cognitive impairment, which contribute to higher risk for cognitive decline related to Alzheimer's disease and related dementias. Sleep and activity are essential for recovery from critical illness, yet ICU survivors experience both sleep deficiency and profound inactivity. About 75-80% of ICU patients experience circadian dysrhythmia, which contributes to cognitive decline and increases likelihood of developing Alzheimer's disease and related dementias. The scientific premises of the proposed study are: 1) a combined sleep promotion and cognitive training intervention will have synergistic effects to mitigate the risk of cognitive impairment and development of Alzheimer's disease and related dementias in older ICU survivors; and 2) chronotherapeutic timing of interventions (i.e., adjusting timing of interventions according to circadian rhythm) may improve intervention efficacy.
Conditions Studied
Interventions
- BEHAVIORAL SLEEP + COG
- BEHAVIORAL COG
- BEHAVIORAL SLEEP
- BEHAVIORAL AC
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-12-26 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06411561
The ClinicalTrials.gov registry entry for NCT06411561 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Dementia appearing as the primary indexed condition, and to 4 interventions - of which SLEEP + COG is the first listed.
NCT06411561 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06411561 about?
NCT06411561 is a clinical study titled "A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors". Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after hospital discharge. Older ICU survivors (ages 60 and older) are at highest risk for delirium and subsequent cognitive impairment, which cont...
What is the current status of trial NCT06411561?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-12-26. Estimated completion is 2027-05-31.
What conditions does trial NCT06411561 study?
This clinical trial studies the following conditions: Dementia, Alzheimers Disease, Cognitive Impairment, Critical Illness, Delirium.
What interventions are being tested in trial NCT06411561?
The interventions under investigation include: SLEEP + COG (BEHAVIORAL), COG (BEHAVIORAL), SLEEP (BEHAVIORAL), AC (BEHAVIORAL).
Who is sponsoring clinical trial NCT06411561?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06411561 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.